Publication date: Jul 14, 2025
Open Access PDF
| Concepts | Keywords |
|---|---|
| Clinical | Care |
| Covid | Clinical |
| Immunocompromised | Covid |
| Infect | Dis |
| Immunocompromised | |
| Infect | |
| Lancet | |
| Patients | |
| Refining |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | COVID-19 |
| disease | MESH | immunocompromised patients |
| drug | DRUGBANK | Coenzyme M |
| disease | MESH | infection |
| disease | MESH | infectious diseases |
| disease | MESH | hypogammaglobulinemia |
| disease | IDO | cell |
| disease | IDO | immunosuppression |
| disease | MESH | sustained viral suppression |
| disease | MESH | malignancies |
| disease | IDO | symptom |
| disease | MESH | recurrence |
| disease | MESH | dysgeusia |
| drug | DRUGBANK | Ritonavir |
| disease | MESH | treatment failure |
Original Article
(Visited 6 times, 1 visits today)